Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Transplantation Proceedings
|
February 1, 1992
Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation
S Kusne, J Fung, M Alessiani, et al.
Transplantation
|
April 15, 1995
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation
R Mañez, S Kusne, M Green, et al.
Transplantation Proceedings
|
August 1, 1993
Posttransplant hypertension in blacks versus nonblacks
V Scantlebury, J McCauley, H Woods, et al.
Annals of the New York Academy of Sciences
|
November 30, 1993
Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy
A W Thomson, J Woo, B Lemster, et al.
Transplantation
|
January 27, 1997
Weaning of immunosuppression in liver transplant recipients
G V Mazariegos, J Reyes, I R Marino, et al.
Pediatric Nephrology (Berlin, Germany)
|
January 1, 1995
FK506 in pediatric kidney transplantation--primary and rescue experience
R Shapiro, V P Scantlebury, M L Jordan, et al.
Transplantation Proceedings
|
February 1, 1995
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events
A B Jain, J J Fung, S Todo, et al.
Transplantation Proceedings
|
June 1, 1994
Water, sodium, potassium, and D-xylose absorption in canine small bowel transplantation
E E Frezza, A Swaminathan, A Asrian, et al.
Annals of Surgery
|
January 1, 1996
Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients
J A Nieto-Rodriguez, S Kusne, R Mañez, et al.
Transplantation Proceedings
|
December 1, 1991
Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients
A B Jain, J J Fung, A G Tzakis, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Transplantation Proceedings
|
February 1, 1992
Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation
S Kusne, J Fung, M Alessiani, et al.
Transplantation
|
April 15, 1995
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation
R Mañez, S Kusne, M Green, et al.
Transplantation Proceedings
|
August 1, 1993
Posttransplant hypertension in blacks versus nonblacks
V Scantlebury, J McCauley, H Woods, et al.
Annals of the New York Academy of Sciences
|
November 30, 1993
Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy
A W Thomson, J Woo, B Lemster, et al.
Transplantation
|
January 27, 1997
Weaning of immunosuppression in liver transplant recipients
G V Mazariegos, J Reyes, I R Marino, et al.
Pediatric Nephrology (Berlin, Germany)
|
January 1, 1995
FK506 in pediatric kidney transplantation--primary and rescue experience
R Shapiro, V P Scantlebury, M L Jordan, et al.
Transplantation Proceedings
|
February 1, 1995
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events
A B Jain, J J Fung, S Todo, et al.
Transplantation Proceedings
|
June 1, 1994
Water, sodium, potassium, and D-xylose absorption in canine small bowel transplantation
E E Frezza, A Swaminathan, A Asrian, et al.
Annals of Surgery
|
January 1, 1996
Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients
J A Nieto-Rodriguez, S Kusne, R Mañez, et al.
Transplantation Proceedings
|
December 1, 1991
Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients
A B Jain, J J Fung, A G Tzakis, et al.
Page
of 9